Clinical Trial Update: Efficacy and Safety of Different Doses of BIRB 796 BS in Patients With Active Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating different doses of BIRB 796 BS in adults with active rheumatoid arthritis has completed. The document reports on efficacy and safety ou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• BIRB 796 BS (BIRB 796)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED